News
Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...
The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.
Eli Lilly and Novo Nordisk already produce popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site ...
Health insurance will grow more expensive in many corners of the market in 2026, and some coverage may shrink.
9hon MSN
Jameela Jamil defends Serena Williams’ right to choose—but cautions the risk of weight loss drugs
Celebrities have access to doctors that most others don’t,” says Jameela Jamil, who flagged the risks of GLP-1s like those ...
Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” second-quarter 2025 ...
Jameela Jamil is clarifying her previous statement regarding Serena Williams and GLP-1s. Here's what she said.
About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry that they’ll ...
Tennis star Serena Williams recently attributed her dramatic weight loss to GLP-1 medication but according to “The Good Place ...
It’s a grand slam partnership for telehealth provider Ro. World renowned tennis star Serena Willams is partnering with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results